Tag: Sitravatinib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Sitravatinib

Fred Alger Management Inc. Invests $394000 in Mirati Therapeutics Inc (MRTX) Stock

Added to Collection on: 2018-07-25 20:56:15

Tags for this article:

Economy
Short
Mirati Therapeutics Inc.
Sitravatinib

Click the tags to see associated articles and topics

View Article Details
Cubist Systematic Strategies LLC Takes Position in Mirati Therapeutics Inc (NASDAQ:MRTX)

Added to Collection on: 2018-08-06 01:10:30

Tags for this article:

Mirati Therapeutics Inc.
Sitravatinib

Click the tags to see associated articles and topics

View Article Details
Mirati Therapeutics Inc (MRTX) Position Cut by EAM Global Investors LLC

Added to Collection on: 2018-08-09 00:36:29

Tags for this article:

Mirati Therapeutics Inc.
Sitravatinib

Click the tags to see associated articles and topics

View Article Details
Mirati Therapeutics Inc (MRTX) Shares Acquired by BlackRock Inc.

Added to Collection on: 2019-01-08 23:17:19

Tags for this article:

Mirati Therapeutics Inc.
Sitravatinib

Click the tags to see associated articles and topics

View Article Details
Mirati Therapeutics Inc (MRTX) Holdings Raised by BlackRock Inc.

Added to Collection on: 2019-01-31 07:37:30

Tags for this article:

Mirati Therapeutics Inc.
Sitravatinib

Click the tags to see associated articles and topics

View Article Details
$-1.22 EPS Expected for Mirati Therapeutics, Inc. (MRTX); Allete (ALE) Has 1.4 Sentiment

Added to Collection on: 2019-07-18 01:48:45

Tags for this article:

Finance
NASDAQ
Economy of the United States
Sitravatinib
S&P 500 INDEX - CBOE

Click the tags to see associated articles and topics

View Article Details
Mirati Therapeutics to Take Part in the 42nd Annual Goldman Sachs Global Healthcare Conference

Added to Collection on: 2021-06-02 20:24:10

Tags for this article:

KRAS
Sitravatinib
Forward-looking statement
Mirati Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Added to Collection on: 2023-01-07 08:59:15

Tags for this article:

Economy
Financial markets
Finance
Corporate finance
Employee stock ownership
Fundamental analysis
Restricted stock
Stock market
Vesting
Forward-looking statement
Sitravatinib
KRAS
Mirati Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Incyte And Mirati Therapeutics Enter Into Clinical Trial Collaboration and Supply Agreement ...

Added to Collection on: 2022-11-07 13:28:43

Tags for this article:

Medicine
Clinical medicine
Cancer treatments
KRAS
Branches of biology
Tyrosine kinase inhibitors
PD-1 and PD-L1 inhibitors
Incyte
PD-L1
Checkpoint inhibitor
Sitravatinib
Mirati Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Mirati Therapeutics (NASDAQ:MRTX) Cut to Market Perform at BMO Capital Markets

Added to Collection on: 2022-12-11 10:01:06

Tags for this article:

Companies
Economy
Financial markets
Pfizer
Johnson & Johnson
Sitravatinib
KRAS
Short
Stock
Mirati Therapeutics
Mirati Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details